Q1 2026 earnings scorecard shows Mag7 at 22.8% growth collapsing to 6.4% once Nvidia is stripped out, with Tech sector up 45% and Health Care down 10.5%.

Mag7 Just 6.4% Ex-Nvidia: The Q1 2026 Earnings Illusion

by
💡 Key Takeaways

  • FactSet’s April 17 data shows Q1 2026 earnings growth at 13.2% blended EPS, revised up from 12.2% the prior week. It’s the sixth straight quarter of double-digit growth.
  • Magnificent 7 earnings grew 22.8%, but ex-Nvidia the rate collapses to 6.4%, while the other 493 S&P 500 names delivered 10.1%.
  • Info Tech led sectors at +45.0%, while Health Care fell -10.5%, the second-deepest drop. Forward 12-month P/E sits at 20.9x, near a historical ceiling.

The Q1 2026 earnings headline reads 13.2%. It’s the sixth straight quarter of double-digit blended EPS growth.

The headline looks pristine. Strip out a single ticker, and the story flips on its head.

FactSet’s S&P 500 earnings season update released on April 17, 2026 exposed the two faces of Q1 2026 earnings. The index is riding six straight quarters of double-digit blended EPS growth, yet the engine is dangerously concentrated: Nvidia plus a 45% jump in the entire Info Tech sector do most of the heavy lifting. Meanwhile, Health Care collapsed to -10.5%, and Forward 12-month P/E has climbed to 20.9x.

The problem is what comes next. UnitedHealth, GE Aerospace, Tesla, and Intel all print Q1 guidance within the week, and the April 28-29 FOMC meeting arrives as year-end rate-hike odds push 52% for the first time. Until Nvidia reports in late May, the S&P 500 earnings narrative effectively rides on one stock.

Q1 2026 earnings AI illustration (AI-generated)
A single semiconductor core sustains S&P 500 earnings growth beneath the bull — AI-generated image by OpenAI DALL-E 3

The 13.2% Reality — How Nvidia Alone Props Up the Magnificent 7

FactSet’s tally puts reporting companies at roughly 10% of the index, around 50 names. Within that sample, blended EPS growth came in at 13.2%, revenue growth at 9.9%, and earnings surprise at 10.8% — well above the five-year average of 78%. On the surface, Q1 2026 looks like a clean extension of the five-quarter uptrend.

The distribution tells a different story. The Magnificent 7 (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) delivered 22.8% earnings growth. The remaining 493 names grew at just 10.1%.

Then FactSet disclosed a critical footnote. Exclude Nvidia, and Mag7 growth collapses to 6.4%. Nvidia alone is the #1 contributor to earnings growth for the Mag7 and the S&P 500 at large.

That caveat reshapes what “13.2%” actually means. The AI infrastructure cycle driving Nvidia’s inference dominance is single-handedly pushing quarterly math higher, while the other six mega-caps grow slower than the index average.

Key point: More than half of the 13.2% headline comes from a single name. Mag7 ex-Nvidia at 6.4% is less than half the index average.
Trader analyzing Q1 2026 S&P 500 earnings data
Mag7 ex-Nvidia at 6.4% exposes the hollow core of Q1 2026 earnings — Photo by Jakub Żerdzicki on Unsplash

88% Beat Rate’s Sector Gap — Tech +45% vs Health Care -10.5%

FactSet’s sector-level YoY earnings growth rates show an extreme spread. Info Tech led at +45.0%, followed by Materials +24.2%, Financials +15.1%, and Utilities +9.6%. On the downside, Health Care fell -10.5%, and Energy was excluded from the eight advancing sectors.

The gap between a 84% revenue beat rate and an 88% EPS beat rate deserves attention. Top-line growth sat at just 9.9%, but earnings surprise hit 10.8% — meaning cost discipline and margin expansion, not revenue, powered this quarter’s earnings. The unspoken story is that operating efficiency, not demand, did most of the work.

Sector polarization shows up immediately at the ETF level. The valuation and earnings gap between tech-heavy XLK and health care XLV should widen as more Q1 prints accumulate, and that forces macro funds to reconsider rotation timing.

  • Advancing sectors: Info Tech +45.0%, Materials +24.2%, Financials +15.1%, Utilities +9.6%
  • Declining sectors: Health Care -10.5%, Energy (negative-growth cohort)
  • 8 of 11 sectors in positive YoY territory — but the top three absorb most of the growth
💡 Related reading
Cerebras Files $25B IPO to Break NVIDIA’s AI Chip Monopoly

BofA and J&J — The Q1 Split Between Finance and Health Care

Individual company prints reinforce the polarization. Bank of America reported Q1 2026 EPS of $1.11 versus the $1.02 consensus, delivered $30.27B in revenue, and raised its 2026 net interest income guidance to 6-8%. The result fits the archetype of the +15.1% Financials sector pattern.

Johnson & Johnson went the opposite way. Q1 2026 operational sales rose +6.4%, revenue came in at $24.1B, and adjusted EPS of $2.70 came with an upward guidance revision.

That’s a rare bright spot against the sector’s -10.5% print. Diversified health care holds its ground, but insurance-heavy names like UnitedHealth — squeezed by rising medical costs — are dragging the average lower.

The pivot point is UnitedHealth’s April 21 Q1 release. The consensus calls for EPS of $6.76 and revenue of $109.84B, and the 2026 full-year medical care ratio (MCR, the share of premium revenue paid out as medical costs) guidance of 88.8% ±50bp is the make-or-break number. If MCR comes in above 88.8%, the Health Care sector drawdown deepens meaningfully.

Q1 2026 earnings season sector leaderboard visual
Tech +45% vs Health Care -10.5% is the defining shape of Q1 2026 earnings — Photo by Shutter Speed on Unsplash

Forward P/E 20.9 Meets 4.5% 10-Year — The Valuation Trap

The S&P 500’s Forward 12-month P/E at 20.9x sits near a historical ceiling. The 10-year Treasury yield is hovering around 4.5% — a level historically associated with market stress. Dividend yields remain near 50-year lows.

The real question isn’t whether 13.2% earnings growth justifies a 20.9x multiple. It’s whether the other 493 names — growing at 10.1% — can defend that multiple if a chunk of the 13.2% comes from one company. When Mag7 ex-Nvidia growth is only 6.4%, half the index already carries the full burden of the premium valuation.

Global risk assets tell a similar story. The STOXX Europe 600 rose +1.91% in the same week, and the dollar index gained +1.7% in Q1.

Global risk-on continues, but bond yields and valuations have already entered stress territory. Rate-hike odds hit 14% in the Fed’s March minutes already, and the path from there to 52% by week’s end flags how fast sentiment is shifting.

In plain terms: A 20.9x Forward P/E is the market saying the index will grow earnings by roughly 1/20 over the next 12 months. If 13.2% growth leans heavily on one stock, that expectation effectively rides on a single ticker.

April 28-29 Fed Meeting, Tariffs, and the Guidance Discount

The next macro lever is the calendar. The April 28-29 FOMC meeting is priced for a hold at 3.50-3.75%. Yet CME FedWatch, per CNBC reporting, pushed the probability of a rate hike by year-end to 52%, breaking above the 50% line for the first time.

From a guidance standpoint, tariffs are another discount factor. The Penn Wharton Budget Model estimated U.S. tariff revenue at $224.8B cumulatively from January 2025 through February 2026.

That works out to an average $1,500 tax increase per household — the largest GDP-proportional tax hike since 1993. A 100% tariff on pharmaceuticals and a 10% Section 122 global duty have been layered on top.

The takeaway question is simple. Can an 88% beat rate paper over the coming wave of guidance cuts?

The April 28-29 FOMC language and early-May inflation data will set the direction for the guidance discount rate. The March dot plot already cut expected 2026 easing to one move, and if April confirms a hawkish tilt, the 20.9x Forward P/E bottom line will need repricing.

Q1 2026 earnings valuation and guidance risk analysis visual
Forward P/E 20.9 plus a 4.5% 10-year yield is the mix that buckles on a single guidance cut — Photo by Towfiqu barbhuiya on Unsplash

April 21-23 High-Beta Earnings — Four Events Investors Will Watch

The first half of the week is a flood of high-beta guidance. On April 21 alone, GE Aerospace, UnitedHealth Group, RTX, Danaher, Northrop Grumman, 3M, DR Horton, Intuitive Surgical, Chubb, Capital One Financial, and United Airlines all deliver Q1 prints.

Tesla and Intel guidance in the immediately following days is the second wave. Both names carry high beta, meaning any guidance shock can cascade into broader sector pricing.

Two sensitivities matter most. First, in the context of Health Care -10.5%, can UnitedHealth defend its MCR guidance?

Second, how much of the tariff burden did aerospace and industrial names (GE, RTX, 3M) actually absorb in this quarter’s numbers? Tesla’s record 164K unsold vehicles could translate directly into demand shock language in the upcoming print.

Here’s the crucial dynamic: the level of punishment for a miss is dictated by guidance shock, not the beat itself. With FactSet’s 10.8% earnings surprise running far above the five-year average of 78%, companies that merely meet consensus guidance are likely to see their stocks penalized. The 88% beat rate has already set a high bar for top-line guidance.

Key point: UnitedHealth’s MCR, Tesla and Intel’s Q1 guidance, and the April 28-29 Fed language — these four events this week form the first filter for repricing Forward P/E 20.9x.
💡 Related reading
Tesla Faces 60% Crash Warning as Unsold Inventory Hits 164K

The Q1 2026 Earnings Checklist to Track

Here’s what investors should monitor through the rest of the earnings cycle. First, Nvidia’s single-ticker contribution and the Mag7 ex-Nvidia 6.4% drift. Until Nvidia’s late-May print, the AI consensus narrative is structurally fragile.

Second, the high-beta guidance of the next two days — Tesla on April 22 and Intel on April 23. Both face the double pressure of tariff exposure and demand shock, and they will be the first real live tests.

Third, track valuation dispersion using sector ETFs (XLV, XLK) against Forward P/E spreads. That spread is where the index’s uneven earnings distribution will show up as cash-flow-weighted price action.

The IMF held its 2026 global growth forecast at 3.3% in the April WEO. Even as the baseline remains intact, corporate guidance has to absorb triple uncertainty from tariffs, oil, and Fed policy — the real test of whether an 88% beat rate can convert to durable 2026 earnings.

Valuation dispersion tracker for Q1 2026 earnings
XLK vs XLV and Forward P/E spread are the dashboard for a hollow 13.2% headline — Photo by Luke Chesser on Unsplash

References

Stay Ahead of the Curve

Get the latest insights on AI, tech, and markets — delivered in both Korean and English.

Explore More Posts

Disclaimer: This article is for informational purposes only and is not investment advice. It does not recommend buying or selling any specific security or digital asset. All investment decisions and their outcomes are the sole responsibility of the reader.